INIS
receptors
100%
mice
100%
injuries
100%
doxorubicin
100%
thrombin
100%
comparative evaluations
50%
control
40%
tissues
20%
administration
20%
plasma
20%
data
10%
levels
10%
reduction
10%
drugs
10%
inhibition
10%
proteins
10%
fibrosis
10%
molecules
10%
heart failure
10%
vehicles
10%
fibroblasts
10%
transgenic mice
10%
prothrombin
10%
Keyphrases
Doxorubicin
100%
Thrombin
100%
Protease-activated Receptor 1 (PAR1)
100%
Cardiac Injury
100%
Cardiac Function
22%
Antithrombin
22%
Cardiotoxicity
22%
Acute Model
22%
Gene-deficient Mice
11%
Heart Failure
11%
Transgenic Mice
11%
Cardiac Troponin
11%
Cardiac Fibrosis
11%
Cardiomyocytes
11%
Coagulation
11%
Activated Protein C
11%
Plasma-thrombin
11%
Tissue Factor
11%
Extracellular Vesicles
11%
Cardiac Fibroblasts
11%
Tissue Factor Expression
11%
Small Molecule Inhibitors
11%
Vehicle Control
11%
Complex Vesicle
11%
Chronic Model
11%
Injury Marker
11%
Prothrombin Fragment 1 + 2
11%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Thrombin
100%
Proteinase Activated Receptor 1
100%
Heart Injury
100%
Thromboplastin
22%
Thrombin Antithrombin Complex
22%
Antiinfective Agent
11%
Transgenic Mouse
11%
Prothrombin
11%
Congestive Heart Failure
11%
Blood Clotting Factor 12
11%
Troponin I
11%
Heart Muscle Fibrosis
11%
Activated Protein C
11%
Biochemistry, Genetics and Molecular Biology
Protease-Activated Receptor
100%
Thrombin
100%
Doxorubicin
100%
Heart Function
22%
Antithrombin
22%
Blood Plasma
22%
Thromboplastin
22%
Wild Type
11%
Small Molecule
11%
Transgenic Mouse
11%
Factor XII
11%
Troponin I
11%
Cardiac Troponin
11%
Prothrombin
11%
Cardiac Muscle Cell
11%
Fibroblast
11%
Protein C
11%